Kyverna Therapeutics (KYTX) Accumulated Depreciation (2023 - 2026)
Kyverna Therapeutics' (KYTX) quarterly Accumulated Depreciation came in at $3.9 million in Q1 2026, down 1.55% YoY from $3.9 million in Q1 2025, and up 3.28% on a QoQ basis from $3.8 million in Q4 2025.
Kyverna Therapeutics (KYTX) Accumulated Depreciation (2023 - 2026) Analysis & Trends
Kyverna Therapeutics (KYTX) has 4 years of Accumulated Depreciation data on file, last reported at $3.9 million in Q1 2026.
- Quarterly Accumulated Depreciation fell 1.55% year-over-year to $3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.9 million (down 1.55% YoY) and the FY2025 annual result came in at $3.8 million, up 2.12% from the prior year.
- Accumulated Depreciation climbed to $3.9 million in Q1 2026, from $3.8 million in the prior quarter.
- In the past five years, Accumulated Depreciation ranged from a high of $4.2 million in Q2 2025 to a low of $2.5 million in Q4 2023.
- A 4-year average of $3.5 million and a median of $3.6 million in 2024 frame the typical range for Accumulated Depreciation.
- Annual changes were most pronounced in 2024 — Accumulated Depreciation soared 47.59% — and 2026, when it declined 1.55%.
- Tracing KYTX's Accumulated Depreciation over 4 years: stood at $2.5 million in 2023, then jumped by 47.59% to $3.7 million in 2024, then grew by 2.12% to $3.8 million in 2025, then climbed by 3.28% to $3.9 million in 2026.
- The last three Accumulated Depreciation figures came in at $3.9 million (Q1 2026), $3.8 million (Q4 2025), and $3.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Kyverna Therapeutics | 505.26 Mn | 505.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.29 Mn |
| Mar 31, 2026 | 3.87 Mn |
| Dec 31, 2025 | 3.75 Mn |
| Sep 30, 2025 | 3.58 Mn |
| Jun 30, 2025 | 4.21 Mn |
| Mar 31, 2025 | 3.93 Mn |
| Dec 31, 2024 | 3.67 Mn |
| Sep 30, 2024 | 3.35 Mn |
| Jun 30, 2024 | 3.03 Mn |
| Mar 31, 2024 | 2.73 Mn |
| Dec 31, 2023 | 2.49 Mn |